Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Friday, July 10, 2009, 7:10PM ET - U.S. Markets Closed. Dow Down 0.45% Nasdaq Up 0.20%
Endocare Inc. (ENDO)At 4:00PM ET: 1.43   0.00 (0.00%)  
MORE ON ENDO
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Endocare Inc.
201 Technology Drive
Irvine, CA 92618
United States - Map
Phone: 949-450-5400
Fax: 949-450-5300
Web Site: http://www.endocare.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Appliances & Equipment
Full Time Employees:120

BUSINESS SUMMARY 
Endocare Inc., a medical device company, engages in the development, manufacture, and distribution of health care products for cryoablation. The cryoablation refers to a technology relating to the use of ice in surgical procedures, and creation of low freezing temperatures inside the body for therapeutic purposes, such as to destroy cells within tissue and tumors. The company’s products include Cryocare surgical system for the treatment of prostate and renal cancer; Cryocare CS system, an on-board and integrated ultrasound unit; CryoGuide, which is a computerized cryoprobe placement, simulation, and guidance system for cryoablation; Cryoprobes that are disposable probes used with the cryocare surgical system; FasTrac, which is a percutaneous access device that allows one-step insertion of cryoprobes; and Urethral Warming Catheter, a disposable catheter used in prostate cryoablation procedures. It also offers Cryocare surgical systems that are configured for interventional radiology and oncology treatments, as well as provides products for the treatment of renal, liver, lung cancer, and palliative intervention. The company sells its cryoablation systems and disposable products to hospitals and mobile service companies, as well as contracts directly with hospitals for the use of its Cryocare surgical system and disposable products on a fee-for-service basis. It offers its products primarily in the United States, China, and Canada. Endocare Inc. has a strategic alliance with Sanarus Medical, Inc., as well as a research and development agreement with CryoDynamics, LLC to design and develop a cryoablation system utilizing nitrogen gas. The company was founded in 1990 and is based in Irvine, California.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Endocare Inc.


    CORPORATE GOVERNANCE 
    Endocare Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Jul-09 is better than 95.4% of CGQ Universe companies and 78.4% of Health Care Equipment & Services companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Michael Rodriguez , 42
    Interim Co-Principal Exec. Officer, Chief Financial Officer, Principal Accounting Officer and Sr. VP of Fin.
    N/A N/A
    Mr. Clint B. Davis , 36
    Interim Co-Principal Exec. Officer, Sr. VP of Legal Affairs, Sec. and Gen. Counsel
    $ 287.00KN/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis